Kalbe Farma (KLBF) – BUY
Price: Rp2,900 – Target Price: Rp2,950
Healthy and Worthy
- In-line FY10 unaudited results.
- Nutritionals division outperforms compared to the other divisions with 18.1% YoY growth while Consumer health division underperform.
- New pharmaceuticals facility for generic drugs tablet.
- Enseval plans for rights issue worth Rp300 billion to expand the distribution network.
- Maintained our buy recommendation and target price of Rp2,950 pending to FY10 audited result. BUY.
- Kalbe Farma (KLBF) – Healthy and Worthy (361.1 KiB)